FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047552592> ?p ?o ?g. }

• W2047552592 endingPage "1948" @default.
• W2047552592 startingPage "1944" @default.
• W2047552592 abstract "Rhizoxin is a macrocyclic lactone compound that binds to tubulin and inhibits microtubule assembly. Rhizoxin demonstrated preclinical anti-tumour activity against a variety of human tumour cell lines and xenograft models. Phase I evaluation found a maximum tolerated rhizoxin dose of 2.6 mg m-2, with reversible, but dose-limiting, mucositis, leucopenia and diarrhoea. Clinical trials were then initiated by the EORTC ECSG in melanoma, breast, head and neck, and non-small-cell lung cancers with the recommended phase II rhizoxin dose of 2 mg m-2. Pharmacological studies were instituted with the phase II trials to complement the limited pharmacokinetic data available from the phase I trial. Blood samples were obtained from 69 of 103 eligible patients enrolled in phase II rhizoxin studies, and these were evaluable for pharmacokinetic analysis in 36 patients. Plasma rhizoxin concentrations were determined by high-performance liquid chromatography (HPLC), and post-distribution pharmacokinetic parameters were estimated by a one-compartment model. Rhizoxin was rapidly eliminated from plasma, with a median systemic clearance of 8.41 min-1 m-2 and an elimination half-life of 10.4 min. Rhizoxin area under the concentration-time curve (AUC) was higher in patients obtaining a partial response or stable disease than in those with progressive disease (median 314 vs 222 ng ml-1 min; P = 0.03). As predicted from previous studies, haematological and gastrointestinal toxicity was observed, but could not be shown to be related to rhizoxin AUC. This study demonstrated the rapid and variable elimination of rhizoxin from the systemic circulation. The presence of pharmacodynamic relationships and the low level of systemic toxicity suggest that future trials of rhizoxin with alternative dosage or treatment schedules are warranted." @default.
• W2047552592 created "2016-06-24" @default.
• W2047552592 creator A5001868238 @default.
• W2047552592 creator A5002272622 @default.
• W2047552592 creator A5002860762 @default.
• W2047552592 creator A5005968451 @default.
• W2047552592 creator A5010489873 @default.
• W2047552592 creator A5011818102 @default.
• W2047552592 creator A5011819733 @default.
• W2047552592 creator A5016647351 @default.
• W2047552592 creator A5071545176 @default.
• W2047552592 creator A5075954613 @default.
• W2047552592 creator A5077163934 @default.
• W2047552592 date "1996-12-01" @default.
• W2047552592 modified "2023-10-07" @default.
• W2047552592 title "Multicentre phase II pharmacological evaluation of rhizoxin" @default.
• W2047552592 cites W1543039510 @default.
• W2047552592 cites W1836451026 @default.
• W2047552592 cites W1986485491 @default.
• W2047552592 cites W1998958639 @default.
• W2047552592 cites W2047481250 @default.
• W2047552592 cites W2067403275 @default.
• W2047552592 cites W2077169776 @default.
• W2047552592 cites W2092707083 @default.
• W2047552592 cites W2132574756 @default.
• W2047552592 cites W2148225636 @default.
• W2047552592 cites W2162168688 @default.
• W2047552592 cites W2165982968 @default.
• W2047552592 cites W2222845202 @default.
• W2047552592 cites W2254709704 @default.
• W2047552592 doi "https://doi.org/10.1038/bjc.1996.657" @default.
• W2047552592 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2074819" @default.
• W2047552592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8980394" @default.
• W2047552592 hasPublicationYear "1996" @default.
• W2047552592 type Work @default.
• W2047552592 sameAs 2047552592 @default.
• W2047552592 citedByCount "36" @default.
• W2047552592 countsByYear W20475525922012 @default.
• W2047552592 countsByYear W20475525922013 @default.
• W2047552592 countsByYear W20475525922014 @default.
• W2047552592 countsByYear W20475525922015 @default.
• W2047552592 countsByYear W20475525922016 @default.
• W2047552592 countsByYear W20475525922018 @default.
• W2047552592 countsByYear W20475525922019 @default.
• W2047552592 crossrefType "journal-article" @default.
• W2047552592 hasAuthorship W2047552592A5001868238 @default.
• W2047552592 hasAuthorship W2047552592A5002272622 @default.
• W2047552592 hasAuthorship W2047552592A5002860762 @default.
• W2047552592 hasAuthorship W2047552592A5005968451 @default.
• W2047552592 hasAuthorship W2047552592A5010489873 @default.
• W2047552592 hasAuthorship W2047552592A5011818102 @default.
• W2047552592 hasAuthorship W2047552592A5011819733 @default.
• W2047552592 hasAuthorship W2047552592A5016647351 @default.
• W2047552592 hasAuthorship W2047552592A5071545176 @default.
• W2047552592 hasAuthorship W2047552592A5075954613 @default.
• W2047552592 hasAuthorship W2047552592A5077163934 @default.
• W2047552592 hasBestOaLocation W20475525922 @default.
• W2047552592 hasConcept C112705442 @default.
• W2047552592 hasConcept C126322002 @default.
• W2047552592 hasConcept C2776694085 @default.
• W2047552592 hasConcept C2778496288 @default.
• W2047552592 hasConcept C2778822529 @default.
• W2047552592 hasConcept C29730261 @default.
• W2047552592 hasConcept C31760486 @default.
• W2047552592 hasConcept C71924100 @default.
• W2047552592 hasConcept C90924648 @default.
• W2047552592 hasConcept C98274493 @default.
• W2047552592 hasConceptScore W2047552592C112705442 @default.
• W2047552592 hasConceptScore W2047552592C126322002 @default.
• W2047552592 hasConceptScore W2047552592C2776694085 @default.
• W2047552592 hasConceptScore W2047552592C2778496288 @default.
• W2047552592 hasConceptScore W2047552592C2778822529 @default.
• W2047552592 hasConceptScore W2047552592C29730261 @default.
• W2047552592 hasConceptScore W2047552592C31760486 @default.
• W2047552592 hasConceptScore W2047552592C71924100 @default.
• W2047552592 hasConceptScore W2047552592C90924648 @default.
• W2047552592 hasConceptScore W2047552592C98274493 @default.
• W2047552592 hasIssue "12" @default.
• W2047552592 hasLocation W20475525921 @default.
• W2047552592 hasLocation W20475525922 @default.
• W2047552592 hasLocation W20475525923 @default.
• W2047552592 hasLocation W20475525924 @default.
• W2047552592 hasLocation W20475525925 @default.
• W2047552592 hasOpenAccess W2047552592 @default.
• W2047552592 hasPrimaryLocation W20475525921 @default.
• W2047552592 hasRelatedWork W1540839883 @default.
• W2047552592 hasRelatedWork W1823675119 @default.
• W2047552592 hasRelatedWork W1991827935 @default.
• W2047552592 hasRelatedWork W1997366816 @default.
• W2047552592 hasRelatedWork W2015679062 @default.
• W2047552592 hasRelatedWork W2076118835 @default.
• W2047552592 hasRelatedWork W2135644280 @default.
• W2047552592 hasRelatedWork W2417380605 @default.
• W2047552592 hasRelatedWork W2433363021 @default.
• W2047552592 hasRelatedWork W2774225352 @default.
• W2047552592 hasVolume "74" @default.
• W2047552592 isParatext "false" @default.
• W2047552592 isRetracted "false" @default.

• next